ARGX:NASDAQ
argenx SE - ADR
928,44Â US$
arrow_downward
-0,22%(-2,08) 1K
928,44Â US$
0,00% (0,00)
bedtimeYopilgandan keyin
Savdolar yopilgan: 7-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoARGX tikeri uchun statistika yaratilmoqda...
Ochish
932,08Â US$
Yuqori
942,68Â US$
Past
921,72Â US$
Bozor kapitali
58,78Â mlrd
Oʻrtacha hajm
259,69Â ming
Hajmi
258,33Â ming
P/E koeffitsiyenti
35,27
52 haftalik eng yuqori
1Â 072,75Â US$
52 haftalik eng past
661,85Â US$
Aksiya boʻyicha daromad
26,32Â US$
Beta
0,45
Muomaladagi aksiyalar
62,89Â mln
Xodimlar soni
2Â ming
Ochish
932,08Â US$
Yuqori
942,68Â US$
Past
921,72Â US$
Bozor kapitali
58,78Â mlrd
Oʻrtacha hajm
259,69Â ming
Hajmi
258,33Â ming
P/E koeffitsiyenti
35,27
52 haftalik eng yuqori
1Â 072,75Â US$
52 haftalik eng past
661,85Â US$
Aksiya boʻyicha daromad
26,32Â US$
Beta
0,45
Muomaladagi aksiyalar
62,89Â mln
Xodimlar soni
2Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
11 soat oldin
Argenx stock after-hours: EUR 839.00, prior close EUR 828.90
Zacks
·
12 soat oldin
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
TradingView
·
13 soat oldin
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
AD HOC NEWS
·
15 soat oldin
Argenx stock gained 1.93 percent as pipeline access expands
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
argenx SE - ADR haqida